SENIOR CONVERTIBLE DEBENTURE DUE JUNE 18, 2022Inspyr Therapeutics, Inc. • June 21st, 2021 • Pharmaceutical preparations • New York
THIS SENIOR CONVERTIBLE DEBENTURE of Inspyr Therapeutics, Inc., a Delaware corporation (the “Company”), having its principal place of business at 2629 Townsgate Road #215, Westlake Village, California 91361, designated as its Senior Convertible Debenture due June 18, 2022 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
